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susceptibility testing, a fear of infection with resistant 
organisms leads to the use of antibiotics which are 
described in the literature as having a very broad 
spectrum while being very easy to administer, i.e. 
quinolones orally and ceftriaxone intramuscularly once 
daily. 
The ceftriaxone resistance was due to an extended- 
spectrum beta-lactamase (ESBL), which could be 
shown to be plasmid mediated, since resistance could 
be transferred during in vitro transconjugation experi- 
ments. Therefore, there is a concern that this resistance 
could spread easily to other commensal and pathogenic 
bacteria in Cambodia. The possibility that this observed 
high resistance rate in E. coli represented clonal disper- 
sion, due to cross-contamination of the doctors during 
the training course, could be excluded by DNA finger- 
printing by means of arbitrarily primed P C R  [l], by 
which only two of the six isolates appeared to have 
identical fingerprints. 
These findings are rather disturbing, although they 
are probably not representative of the entire population, 
since probably only the doctors and the wealthy can 
afford self-treatment and treatment with the newer 
and more expensive antibiotics. These data illustrate 
that resistance can be very high even in developing 
countries and suggest that laboratory facilities may 
form an essential part of medical progress, especially 
important for diagnostic and therapeutic strategies. 
In a recent study, ESBLs were detected in 26% of 
Enterobacteriaceae isolated in a hospital inThailand [2]. 
These data and our limited experience illustrate that 
studies on susceptibility of bacteria in developing 
countries should be performed urgently and the results 
disseminated widely in order to enhance appropriate 
use of antibiotics. Possibly, the treatment advocated by 
the WHO, using cheap antibiotics, may be insufficient 
in certain situations. 
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Macrolide, lincosamide and streptogramin (MLS) 
antibiotics are chemically distinct, but are &ke in their 
mode of action, which is inhibition of protein synthesis 
by binding to the 23s component of the 50s ribosomal 
subunit. Three mechanisms of MLS resistance are most 
frequently encountered: (1) enzymatic target modifi- 
cation by an N6-dimethylase [l-31; (2) enzymatic 
inactivation by (a) 3-lin 4-cli 0-nucleotidyltransferase 
( l i d ) ,  (b) streptogramin A acetyltransferase (saa), and 
(c) streptogramin B hydrolase (sbh) [4-61; and (3) active 
efflux resulting in hampered erythromycin perme- 
ability (erpA) or macrolide streptogramin permeability 
(msrA) [7-91. In staphylococci, N6-dimethylase activity 
can either be constitutively expressed, or be induced by 
the presence of a macrolide. Although in the former 
situation (constitutive expression) resistance to all 
macrolide, lincosamide and streptogramin B antibiotics 
is readily detected by agar diffusion, isolates resistant to 
14- and 15-membered macrolides may still appear 
susceptible to clindamycin in the latter (inducible 
expression) [lo]. The National Committee for Clinical 
Laboratory Standards (NCCLS) guidelines for 
performing susceptibility testing by disk diffusion do 
not specifically address this issue [ll], and have been 
shown to be unreliable in detecting inducible N6- 
dimethylase activity [12]. To overcome this problem, a 
modification with the addition of lincomycin has 
recently been suggested [13]. 
During a 3-month period our laboratory 
augmented the standard susceptibility testing procedure 
(NCCLS; erythromycin and clindamycin disks not 
apposed) by including a lincomycin disk on a separate 
agar plate (Mueller-Hinton 2 cation-adjusted agar, 
bioMhrieux, Crapone, France). Erythromycin (15 pg; 
Becton Dickinson, Meylan Cedex, France) and 
clindamycin (2 pg; Becton Dickinson, Meylan Cedex, 
France) zone diameters were interpreted accordmg 
to the NCCLS guidelines [ l l ] .  Interpretations of 
lincomycin (1 5 pg; bioMkrieux, Marcy l’Etoile, 
France) zone diameters were those provided by the 
manufacturer (susceptible, 2 2 1  mm; intermediate, 18- 
20 mm; resistant, 5 17 mm). 
Staphylococci were defined as catalase-positive, 
Gram-positive cocci in clusters. Staphylococcus aureus 
and coagulase-negative staphylococci (CNS) were 
differentiated on the basis of DNase activity and free 
coagulase production. Doubtful results were confirmed 
by Staphylococcus aureus Accuprobe (Gen-Probe, San 
Diego, CA). CNS were not hrther identified to the 
species level. 
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Figure 1 Modified disk diffusion method in which the 
erythroinyciii disk (E; 15 pg) was placed in between the 
clindamycin (CC; 2 pg) and lincomycin (L; 15 pg) dlsks 
respectively. (a) Erythromycin N"-dimethylase, constitutive 
expression (erm). (b) Erythromycin N"-dimethylase, 
inducible expression (erni). (c) 3-lin 4-cli 0- 
nucleotidyltransferase ( l i d ) .  (d) Erythromycin permeability 
(erpA) or macrolide streptogramin pernieability (msrA). (e) 
Streptograinin A acetyltransferase (saa) or streptogranin B 
hydrolase (sbh). 
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(a) (b) 
Figure 2 Disk diffusion method without (a) and with (b) apposition of the clindamycin disk (CC; 2 pg) next to the 
erythromycin disk (E; 15 pg). VA, vancomycin; OX, oxacihn; Te, tetracycline; CIP, ciprofloxacin. 
In total, 444 consecutive patient isolates (324 S. 
aureus, and 120 CNS) that were considered clinically 
significant were investigated. The augmented screening 
procedure detected 59 (13.3%) isolates revealing 
reduced susceptibility to any of the three antibiotics 
comprising 18 (5.5%) S. aureus and 41 (34.2%) CNS, 
with the following susceptibility patterns: erythro- 
mycin, lincomycin and clindamycin resistant, n=27; 
erythromycin monoresistant, n=24; lincomycin 
monoresistant, n=2; intermediate to lincomycin, n= 1; 
lincomycin resistant and intermediate to clindamycin, 
n=5. Thus, three isolates (S. aureus, n = l ;  CNS, n=2) 
showing reduced susceptibility to linconiycin were 
only detected by the augmented screening. 
Thirty-eight of the 59 resistant isolates (erythro- 
mycin, lincomycin, and clindamycin resistant, n= 19; 
erythromycin monoresistant, n= 14; lincomycin 
monoresistant, y1= 1; intermediate to lincomycin, n= 1; 
lincomycin resistant and intermediate to clindamycin, 
n=3) were available for retesting both by the NCCLS 
standard procedure and by a modified disk diffusion 
method in which the erythromycin disk was placed in 
between the clindamycin and lincomycin disks 
(distance 15 mm). From susceptibility patterns (Figure 
1) the isolates were classified according to the putative 
resistance mechanisms [12]: (a) constitutive N6- 
dimethylase, n=18 (S. uureus, n=3; CNS, n=15); (b) 
inducible N6-dimethylase, n= 14 (S .  uureus, n=3 ;  
CNS, n = l l ) ;  (c) linA, n=4 (S .  uureus, n=3; CNS, 
n=l);  (d) msrA or erpA, n = l  (CNS); (e) sad or sbh, 
n = l  (CNS). Differentiating saa from sbh and erpA 
from msrA was not possible, since streptogramins were 
not tested [12]. 
Comparison of the modified to the NCCLS 
standard procedure revealed unequivocal results regard- 
ing the 18 isolates harboring constitutively expressed 
W-hrnethylase and one isolate showing msrA or erpA 
activity. The modified procedure identified inducible 
N6-dimethylase activity in 14 additional isolates, 
irrespective of the lincosamide tested (Figure lb); l i d  
and saa or sbh activity, respectively, in one isolate each, 
however, were only detected by lincomycin (Figure 
lc,e). By the NCCLS standard procedure (erythro- 
mycin and clindamycin disks not apposed), 13 of 14 
isolates with inducible N6-dimethylase activity 
appeared to be clindamycin-susceptible (Figure 2a), but 
apposing clindamycin next to erythromycin disks 
resulted in the detection of lincosamide resistance 
conferred by this mechanism in all 14 isolates (Figure 
2b). Although there is still controversy over the clinical 
significance of clindamycin resistance conferred by 
inducible N6-dimethylase activity, relapse in patients 
with staphylococcal infections who were treated with 
clindamycin has been reported [14]. 
While it reliably detected inducible N6-dimethy- 
lase activity when apposed next to the erythromycin 
disk, clindamycin alone detected only three of four 
isolates with resistance conferred by linA (Figure lc). 
The proper detection of this resistance mechanism, 
which greatly impairs the activities of both lincomycin 
and clindamycin in vitro [13], is a prerequisite for 
assessing its clinical significance, and, since clindamycin 
Shor t  Commun ica t i ons  and Le t te rs  t o  the  Ed i to rs  7 0 5  
is still an important drug for the treatment of 
staphylococcal infections, the detection of any 
mechanism conferring resistance to this drug may be 
important for predicting the clinical outcome. 
Our findings confirm that the reliable detection of 
MLS resistance conferred by inducible N'-dimethylase 
activity in staphylococci by disk diffusion requires the 
apposition of the lincosamide next to the erythromycin 
disk; the substitution of lincomycin for clindamycin 
further increases the sensitivity of the resistance 
screening. 
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Nasop haryngeal carriage of Streptococcus pneumoniae 
in children's day-care centers: 10-month follow-up 
study in Nice, France 
Clin Microbiol Infect 1997; 3: 705-708 
Streptococcus pneumoniae (SP) is one of the most fre- 
quently encountered bacterial species in respiratory 
tract infections, occasionally leading to potentially 
life-threatening complications (meningitis, septicemia). 
Since 1987, a steady increase in resistance has been 
observed in France, with rates reaching 32% in 1994 
[l]. Every child carries SP at  some time during the year 
and this organism is responsible for the majority of 
bacterial infections between 3 months and 3 years of 
age [2]. However, epidemic processes within day-care 
centers do not appear to have been investigated to date. 
The object of this study was to assess the prevalence and 
incidence of nasopharyngeal carriage of penicillin- 
resistant pneumococci (PRP), and identifi- risk factors 
associated with carriage in a cohort of children attend- 
ing day-care centers in south-eastern France. 
A prospective longitudinal study was conducted 
between September 1994 and June 1995 in three day- 
care centers in the town of Nice, France. Two of these 
were hospital day-care centers catering for children of 
hospital staff (DCCs A and P), while the third was a 
private center (DCC S). A nasopharyngeal sample was 
collected monthly starting at  inclusion and for as long 
as the child attended the center. Care-givers and parents 
were interviewed each time to investigate recent upper 
or lower respiratory tract infections and/or anti- 
microbial treatment. Samples were collected with a 
flexible Vygon 522.06 tube fitted onto a 1-mL syringe 
and introduced into one of the child's nostrils. SP 
strains were tested for susceptibility to oxacdin by the 
Kirby-Bauer method. Susceptibility to penicillin was 
